相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants
M. J. Cardoso et al.
BREAST (2019)
Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers
Sherene Loi et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
G. von Minckwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Breast conserving therapy and mastectomy revisited: Breast cancer-specific survival and the influence of prognostic factors in 129,692 patients
Mirelle Lagendijk et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
Maria Vittoria Dieci et al.
SEMINARS IN CANCER BIOLOGY (2018)
Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy
Eileen Rakovitch et al.
BREAST (2018)
Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data
Matteo Lambertini et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial
Sibylle Loibl et al.
LANCET ONCOLOGY (2018)
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
P. A. Francis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
J. A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Effect of Adjuvant Trastuzumab for a Duration of 9 Weeks vs 1 Year With Concomitant Chemotherapy for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer The SOLD Randomized Clinical Trial
Heikki Joensuu et al.
JAMA ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
PERSEPHONE: 6 versus 12 months (m) of adjuvant trastuzumab in patients (pts) with HER2 positive (+) early breast cancer (EBC): Randomised phase 3 non-inferiority trial with definitive 4-year (yr) disease-free survival (DFS) results.
Helena Margaret Earl et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Intraoperative Ultrasound-Guided Excision of Axillary Clip in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Therapy (ILINA Trial) A New Tool to Guide the Excision of the Clipped Node After Neoadjuvant Treatment
Christian Siso et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
M. J. Duffy et al.
EUROPEAN JOURNAL OF CANCER (2017)
European Breast Cancer Conference manifesto on breast centres/units
Fatima Cardoso et al.
EUROPEAN JOURNAL OF CANCER (2017)
Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis The ACOSOG Z0011 (Alliance) Randomized Clinical Trial
Armando E. Giuliano et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Karoline B. Kuchenbaecker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology)
Joanne L. Blum et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update
Ian Krop et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Gary H. Lyman et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline
Sukhbinder Dhesy-Thind et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial
Charlotte E. Coles et al.
LANCET (2017)
11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial
David Cameron et al.
LANCET (2017)
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
Miguel Martin et al.
LANCET ONCOLOGY (2017)
Late side-eff ects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial
Csaba Polgar et al.
LANCET ONCOLOGY (2017)
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
Hongchao Pan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
N. Masuda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer
Gunter von Minckwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Ki67 assessment in breast cancer: an update
Frederique Penault-Llorca et al.
PATHOLOGY (2017)
Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim Trial
Peter S. Hall et al.
VALUE IN HEALTH (2017)
Comparable Survival between Additional Radiotherapy and Local Surgery in Occult Breast Cancer after Axillary Lymph Node Dissection: A Population-based Analysis
San-Gang Wu et al.
JOURNAL OF CANCER (2017)
Germline Mutation Status, Pathological Complete Response, and Disease-Free Survival in Triple-Negative Breast Cancer Secondary Analysis of the GeparSixto Randomized Clinical Trial
Eric Hahnen et al.
JAMA ONCOLOGY (2017)
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue A Meta-analysis
Karen M. Mustian et al.
JAMA ONCOLOGY (2017)
Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades
Laura J. Esserman et al.
JAMA ONCOLOGY (2017)
Clinical validity and Utility of Tumor-infiltrating Lymphocytes in Routine Clinical Practice for Breast Cancer Patients: Current and Future Directions
Lironne Wein et al.
FRONTIERS IN ONCOLOGY (2017)
ESMO-Magnitude of Clinical Benefit Scale version 1.1
N. I. Cherny et al.
ANNALS OF ONCOLOGY (2017)
ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3)
Shani Paluch-Shimon et al.
BREAST (2017)
Less is more. Breast conservation might be even better than mastectomy in early breast cancer patients
Oreste D. Gentilini et al.
BREAST (2017)
Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial
Ulrike Nitz et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Patterns of care for ductal carcinoma in situ of the breast: Queensland's experience over a decade
Samantha Barbour et al.
BREAST (2017)
Factors Influencing Management and Outcome in Patients with Occult Breast Cancer with Axillary Lymph Node Involvement: Analysis of the National Cancer Database
Lindsay K. Hessler et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
G. Curigliano et al.
ANNALS OF ONCOLOGY (2017)
Breast Cancer-Major Changes in the American Joint Committee on Cancer Eighth Edition Cancer Staging Manual
Armando E. Giuliano et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG
Peyman Hadji et al.
JOURNAL OF BONE ONCOLOGY (2017)
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: Results of the phase III multicentric Italian study Short-HER
Pier Franco Conte et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement
Candace Correa et al.
PRACTICAL RADIATION ONCOLOGY (2017)
Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review
Kandice K. Ludwig et al.
AMERICAN JOURNAL OF SURGERY (2016)
Is sentinel lymph node biopsy a viable alternative to complete axillary dissection following neoadjuvant chemotherapy in women with node-positive breast cancer at diagnosis? An updated meta-analysis involving 3,398 patients
Hiba El Hage Chehade et al.
AMERICAN JOURNAL OF SURGERY (2016)
Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening
S. Paluch-Shimon et al.
ANNALS OF ONCOLOGY (2016)
Papillary Lesions of the Breast An Update
Shi Wei
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2016)
Psychosocial and Sexual Well-Being Following Nipple-Sparing Mastectomy and Reconstruction
Cindy H. Wei et al.
BREAST JOURNAL (2016)
Sentinel node biopsy after neoadjuvant treatment in breast cancer: Five-year follow-up of patients with clinically node-negative or node-positive disease before treatment
V. Galimberti et al.
EJSO (2016)
Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ
Monica Morrow et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection
Abigail S. Caudle et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer
Lise Bech Jellesmark Thorsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial
Martine Piccart-Gebhart et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial
John F. Forbes et al.
LANCET (2016)
Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial
Richard G. Margolese et al.
LANCET (2016)
10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study
Marissa C. van Maaren et al.
LANCET ONCOLOGY (2016)
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
F. Cardoso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Summary
Lyndsay N. Harris et al.
JOURNAL OF ONCOLOGY PRACTICE (2016)
Breast-cancer-specific mortality in patients treated based on the 21-gene assay: a SEER population-based study
Valentina I. Petkov et al.
NPJ BREAST CANCER (2016)
Central venous access in oncology: ESMO Clinical Practice GuidelinesaEuro
B. Sousa et al.
ANNALS OF ONCOLOGY (2015)
Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration
V. Bossuyt et al.
ANNALS OF ONCOLOGY (2015)
Marking Axillary Lymph Nodes With Radioactive Iodine Seeds for Axillary Staging After Neoadjuvant Systemic Treatment in Breast Cancer Patients The MARI Procedure
Mila Donker et al.
ANNALS OF SURGERY (2015)
Overall Survival, Disease-Free Survival, Local Recurrence, and Nipple-Areolar Recurrence in the Setting of Nipple-Sparing Mastectomy: A Meta-Analysis and Systematic Review
Lucy De La Cruz et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
The Society of Surgical Oncology-American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer Perspectives for Pathologists
Stuart J. Schnitt et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2015)
Incidence and Time Path of Lymphedema in Sentinel Node Negative Breast Cancer Patients: A Systematic Review
Nick Gebruers et al.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2015)
Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial
Lorenzo Livi et al.
EUROPEAN JOURNAL OF CANCER (2015)
Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)
William M. Sikov et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
Claudia Allemani et al.
LANCET (2015)
Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial
Harry Bartelink et al.
LANCET ONCOLOGY (2015)
Current management of lesions associated with an increased risk of breast cancer
Monica Morrow et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer
Sara M. Tolaney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Breast-Cancer Screening - Viewpoint of the IARC Working Group
Beatrice Lauby-Secretan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Regional Nodal Irradiation in Early-Stage Breast Cancer
Timothy J. Whelan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Adjuvant Ovarian Suppression in Premenopausal Breast Cancer
Prudence A. Francis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer
P. M. Poortmans et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy
Halle C. F. Moore et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Bilateral Mastectomy versus Breast-Conserving Surgery for Early-Stage Breast Cancer: The Role of Breast Reconstruction
Claudia R. Albornoz et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2015)
ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer
Birgitte V. Offersen et al.
RADIOTHERAPY AND ONCOLOGY (2015)
Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial
F. Perrone et al.
ANNALS OF ONCOLOGY (2015)
A Systematic Review of Complications of Implant-based Breast Reconstruction with Prereconstruction and Postreconstruction Radiotherapy
Adeyiza O. Momoh et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
A Systematic Review of Morbidity Associated with Autologous Breast Reconstruction Before and After Exposure to Radiotherapy: Are Current Practices Ideal?
Brian P. Kelley et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Molecular and protein markers for clinical decision making in breast cancer: Today and tomorrow
Nadia Harbeck et al.
CANCER TREATMENT REVIEWS (2014)
Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831
Edith A. Perez et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Radiation Field Design in the ACOSOG Z0011 (Alliance) Trial
Reshma Jagsi et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Society of Surgical Oncology-American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer
Meena S. Moran et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial
Jayant S. Vaidya et al.
LANCET (2014)
Postmastectomy radiation in breast cancer with one to three involved lymph nodes: ending the debate
Philip Poortmans
LANCET (2014)
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
P. McGale et al.
LANCET (2014)
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
Patricia Cortazar et al.
LANCET (2014)
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial
Gunter von Minckwitz et al.
LANCET ONCOLOGY (2014)
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial
Mila Donker et al.
LANCET ONCOLOGY (2014)
Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2x2 factorial randomised phase 3 trial
Helena M. Earl et al.
LANCET ONCOLOGY (2014)
Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial
Robert Coleman et al.
LANCET ONCOLOGY (2014)
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
Olivia Pagani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Attitudes of young patients with breast cancer toward fertility loss related to adjuvant systemic therapies. EORTC study 10002 BIG 3-98
Elzbieta Senkus et al.
PSYCHO-ONCOLOGY (2014)
Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement
H. A. Azim et al.
ANNALS OF ONCOLOGY (2013)
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2013)
Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a standard chemotherapy regimen: The CASA randomized trial
Diana Crivellari et al.
BREAST (2013)
Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients
Holm Eggemann et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Survival after lumpectomy and mastectomy for early stage invasive breast cancer
E. Shelley Hwang et al.
CANCER (2013)
The requirements of a specialist Breast Centre
A. R. M. Wilson et al.
EUROPEAN JOURNAL OF CANCER (2013)
An update on male breast cancer and future directions for research and treatment
Sousa Berta et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000-2002
Claudia Allemani et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study
C. A. Drukker et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer The ACOSOG Z1071 (Alliance) Clinical Trial
Judy C. Boughey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
Christina Davies et al.
LANCET (2013)
2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial
Aron Goldhirsch et al.
LANCET (2013)
Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial
Umberto Veronesi et al.
LANCET ONCOLOGY (2013)
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial
Viviana Galimberti et al.
LANCET ONCOLOGY (2013)
6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial
Xavier Pivot et al.
LANCET ONCOLOGY (2013)
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study
Thorsten Kuehn et al.
LANCET ONCOLOGY (2013)
Sequential versus concurrent anthracyclines and taxanes as adjuvant chemotherapy of early breast cancer: A meta-analysis of phase III randomized control trials
Nan Shao et al.
BREAST (2012)
Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry
Seho Park et al.
BREAST (2012)
18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques
Bas B. Koolen et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: a meta-analysis
Xiaosong Chen et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Disease-Related Outcomes With Long-Term Follow-Up: An Updated Analysis of the Intergroup Exemestane Study
Judith M. Bliss et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Preoperative Chemotherapy Plus Trastuzumab, Lapatinib, or Both in Human Epidermal Growth Factor Receptor 2-Positive Operable Breast Cancer: Results of the Randomized Phase II CHER-LOB Study
Valentina Guarneri et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
Jose Baselga et al.
LANCET (2012)
Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial
Norikazu Masuda et al.
LANCET ONCOLOGY (2012)
Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)
Laura Biganzoli et al.
LANCET ONCOLOGY (2012)
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
Luca Gianni et al.
LANCET ONCOLOGY (2012)
FDG-PET/CT in the staging of local/regional metastases in breast cancer
Ian J. Robertson et al.
BREAST (2011)
Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials
Gunter von Minckwitz et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
A population-based validation of the prognostic model PREDICT for early breast cancer
G. C. Wishart et al.
EJSO (2011)
Association of Occult Metastases in Sentinel Lymph Nodes and Bone Marrow With Survival Among Women With Early-Stage Invasive Breast Cancer
Armando E. Giuliano et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
Mitch Dowsett et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials
LANCET (2011)
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8.1 years median follow-up
Meredith M. Regan et al.
LANCET ONCOLOGY (2011)
Adjuvant Trastuzumab in HER2-Positive Breast Cancer
Dennis Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Nomogram to predict ipsilateral breast relapse based on pathology review from the EORTC 22881-10882 boost versus no boost trial
Erik van Werkhoven et al.
RADIOTHERAPY AND ONCOLOGY (2011)
ASCO-CAP Guidelines for Breast Predictive Factor Testing: An Update
M. Elizabeth Hale Hammond
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2011)
Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study
H. Eidtmann et al.
ANNALS OF ONCOLOGY (2010)
Male breast cancer
Laura Ottini et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2010)
Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy
Nehmat Houssami et al.
EUROPEAN JOURNAL OF CANCER (2010)
Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working group
Francesco Sardanelli et al.
EUROPEAN JOURNAL OF CANCER (2010)
Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen
Mitch Dowsett et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer
Harold J. Burstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Coprescription of Tamoxifen and Medications That Inhibit CYP2D6
Kostandinos Sideras et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations
Larissa A. Korde et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Pathology evaluation of sentinel lymph nodes in breast cancer: protocol recommendations and rationale
Donald L. Weaver
MODERN PATHOLOGY (2010)
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial
Jack Cuzick et al.
LANCET ONCOLOGY (2010)
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
David N. Krag et al.
LANCET ONCOLOGY (2010)
Amenorrhea from Breast Cancer Therapy -- Not a Matter of Dose.
Sandra M. Swain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
Timothy J. Whelan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: Recommendations of the Groupe Europeen de Curietherapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009)
Csaba Polgar et al.
RADIOTHERAPY AND ONCOLOGY (2010)
Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database
Philippe Autier et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Post-operative radiotherapy for ductal carcinoma in situ of the breast - A systematic review of the randomised trials
Annabel Goodwin et al.
BREAST (2009)
Effect of postoperative radiotherapy on autologous deep inferior epigastric perforator flap volume after immediate breast reconstruction
J. S. Chatterjee et al.
BRITISH JOURNAL OF SURGERY (2009)
Surgical guidelines for the management of breast cancer Association of Breast Surgery at BASO 2009
[Anonymous]
EJSO (2009)
High Risk of Recurrence for Patients With Breast Cancer Who Have Human Epidermal Growth Factor Receptor 2-Positive, Node-Negative Tumors 1 cm or Smaller
Ana M. Gonzalez-Angulo et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735
Stephen Jones et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase III Trial Evaluating the Addition of Paclitaxel to Doxorubicin Followed by Cyclophosphamide, Methotrexate, and Fluorouracil, As Adjuvant or Primary Systemic Therapy: European Cooperative Trial in Operable Breast Cancer
Luca Gianni et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial
Heikki Joensuu et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
Richard M. Simon et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial
Kathy S. Albain et al.
LANCET (2009)
Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer
Hyman B. Muss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
Michael Gnant et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Systematic review: Using magnetic resonance imaging to screen women at high risk for breast cancer
Ellen Warner et al.
ANNALS OF INTERNAL MEDICINE (2008)
Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen
Paul E. Goss et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Preoperative chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
Priya Rastogi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Increased risk of recurrence after hormone replacement therapy in breast cancer survivors
Lars Holmberg et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial
LANCET (2008)
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial
LANCET ONCOLOGY (2008)
Options in reconstructing the irradiated breast
Scott L. Spear et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2008)
European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition - summary document
N. Perry et al.
ANNALS OF ONCOLOGY (2008)
Measurement of residual breast cancer burden to predict survival after Neoadjuvant chemotherapy
W. Fraser Symmans et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: A multi-institutional audit
Katrina H. Moore et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy
P. Meijnen et al.
BRITISH JOURNAL OF SURGERY (2007)
Reading the prognosis of the individual with breast cancer
R. W. Blamey et al.
EUROPEAN JOURNAL OF CANCER (2007)
Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer
Caroline Lohrisch et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Tumour-positive sentinel node findings in patients with ductal carcinoma in situ
M. Leidenius et al.
JOURNAL OF SURGICAL ONCOLOGY (2006)
American Society of Clinical Oncology recommendations on fertility preservation in cancer patients
Stephanie J. Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer - The Pre-Operative Arimidex Compared to Tamoxilen (PROAC7) trial
L Cataliotti et al.
CANCER (2006)
Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer
DA Berry et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: The Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial
IE Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Reliance on hormone receptor assays of surgical specimens may compromise outcome in patients with breast cancer
GB Mann et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: A guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ
TWF Yen et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2005)
Radiotherapy for breast cancer in patients undergoing breast reconstruction or augmentation
E Senkus-Konefka et al.
CANCER TREATMENT REVIEWS (2004)
A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer
PE Goss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of intergroup trial C9741/cancer and leukemia group B trial 9741
ML Citron et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Behavioral risk factors in breast cancer: Can risk be modified?
A McTiernan
ONCOLOGIST (2003)
Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients
CA Dykewicz
CLINICAL INFECTIOUS DISEASES (2001)
Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer
PM Ravdin et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study
W Eiermann et al.
ANNALS OF ONCOLOGY (2001)
分享论文
